Cheeseman Chris
Membrane Protein Research Group, Department of Physiology, University of Alberta, Edmonton, Alberta, Canada.
Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E238-41. doi: 10.1152/ajpendo.90394.2008. Epub 2008 May 13.
The very last member of the SLC2A gene family of facilitated hexose transporters to be cloned was SLC2A7 (hGLUT7). It has been assigned to the class II of the GLUT family on the basis of sequence similarity, and its closest family member is GLUT5, an intestinal fructose transporter. GLUT7 is primarily expressed in the small intestine and colon, although mRNA has been detected in the testis and prostate as well. The protein is expressed in the apical membrane of the small intestine and colon, and it has a high affinity (<0.5 mM) for glucose and fructose. The abundance of the protein in the small intestine does change in parallel with the dietary carbohydrate. However, the distribution of GLUT7 along the small intestine does not entirely match with the availability of glucose and fructose, suggesting that the physiological substrate for this transporter has yet to be identified. Unlike GLUT13, the proton-coupled myoinositol transporter (HMIT), there is no evidence for the coupling of protons to the hexose movement via GLUT7. One area of study in which GLUT7 has provided a useful comparison with GLUT1 has been in the development of the hypothesis that the facilitated hexose transporters may have a selectivity filter at the exofacial opening of the translocation pore, which helps to determine which hexoses can be transported. If substantiated, the elucidation of this mechanism may prove useful in the design of hexose analogs for use in cancer imaging and therapeutics.
己糖易化转运蛋白SLC2A基因家族中最后一个被克隆的成员是SLC2A7(hGLUT7)。基于序列相似性,它被归为GLUT家族的II类,其最接近的家族成员是肠道果糖转运蛋白GLUT5。GLUT7主要在小肠和结肠中表达,不过在睾丸和前列腺中也检测到了其mRNA。该蛋白在小肠和结肠的顶端膜中表达,对葡萄糖和果糖具有高亲和力(<0.5 mM)。小肠中该蛋白的丰度确实会随饮食中的碳水化合物而平行变化。然而,GLUT7在小肠中的分布与葡萄糖和果糖的可利用性并不完全匹配,这表明该转运蛋白的生理底物尚未确定。与质子偶联的肌醇转运蛋白(HMIT)GLUT13不同,没有证据表明质子通过GLUT7与己糖转运相偶联。GLUT7与GLUT1进行有用比较的一个研究领域是关于易化己糖转运蛋白可能在转运孔外表面开口处有一个选择性过滤器的假说的发展,该过滤器有助于确定哪些己糖可以被转运。如果得到证实,阐明这一机制可能在用于癌症成像和治疗的己糖类似物的设计中被证明是有用的。